FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/02/081197 [Registered on: 24/02/2025] Trial Registered Prospectively
Last Modified On: 21/02/2025
Post Graduate Thesis  No 
Type of Trial  PMS 
Type of Study   Medical Device 
Study Design  Single Arm Study 
Public Title of Study   Participants will be enrolled in a Post Market Clinical Study where the safety and performance of skanrays anesthetic workstations will be evaluated 
Scientific Title of Study   Post Market Clinical Study of Skanrays Anesthetic Workstations - SkanSiesta Pro 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
3-75-010-0118-12 Version 01 Date 03 October 2024  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr VY Srinivas 
Designation  Head of the department - Anesthesia  
Affiliation  Krishna Rajendra Hospital, Mysore 
Address  Department of anesthesia Krishna Rajendra Hospital Irwin Rd Devaraja Mohalla Yadavagiri Mysuru Karnataka

Mysore
KARNATAKA
570001
India 
Phone  9448165082  
Fax    
Email  drsrinivasvy@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Vivek Nayak 
Designation  Assistant Professor 
Affiliation  Krishna Rajendra Hospital, Mysore 
Address  Department of anesthesia Krishna Rajendra Hospital Irwin Rd Devaraja Mohalla Yadavagiri Mysuru Karnataka

Mysore
KARNATAKA
570001
India 
Phone  8088705464  
Fax    
Email  viveknayak007@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Vasundhara R  
Designation  Head - Regulatory affaris  
Affiliation  Skanray Technologies Limited  
Address  Department of regulatory affairs Skanray Technologies Limited Plot #15-17 Hebbal Industrial Area Mysore Karnataka

Mysore
KARNATAKA
570016
India 
Phone  9844761818  
Fax    
Email  vasundhara.r@skanray.com  
 
Source of Monetary or Material Support  
Skanray Technologies Limited Plot #15-17 Hebbal industrial area Karnataka Mysore India 570016 
 
Primary Sponsor  
Name  Skanray Technologies Limited 
Address  Plot # 15-17, Hebbal Industrial Area, Mysore 570016 
Type of Sponsor  Other [Medical Device Manufacturer] 
 
Details of Secondary Sponsor  
Name  Address 
Skanray Technologies Limited  Plot # 15-17, Hebbal Industrial Area, Mysore 570016 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr VY Srinivas  Krishna Rajendra Hospital  Department of anesthesia Krishna Rajendra Hospital Irwin Rd Devaraja Mohalla Yadavagiri Mysuru Karnataka - 570001
Mysore
KARNATAKA 
9448165082

drsrinivasvy@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics committee Mysore Medical college and Research Institute and Associated Hospitals  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Approved/Obtained 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NIL 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  2.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  Adult and pediatric subjects of age more than two year or body weight of 10 kg above whichever is lower and of either gender.The subjects belongs to the category of ASA1 physical status shall be included. (Note: ASA2 ASA3 ASA4 and ASA5 classified physical status subjects shall be included after the completion of the
pilot phase).Subject or the legally authorized representative on behalf of the
subject shall be capable of understanding and signing the informed consent form 
 
ExclusionCriteria 
Details  Subjects with age less than two year or less than 10 kg of body
weight.Pregnant population shall be excluded 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Assessing the adequate patient oxygenation,ventilation and delivery of anesthetic gas mixtures in accordance with need of the subjectsthroughout the surgery. Determining the performance in terms of delivered parameters against the intended or set values for the specific subject condition. Determine the possible unknown adverse events,undesirable side effects associated with use of the device.  For 60 minutes surgery: 0,12,24,36,48,60th
minute.
For 120 minutes surgery: 0,24,48,72,96,120th
minute.
For 360 minutes surgery: 0, 36,72,108,144,180
minute. 
 
Secondary Outcome  
Outcome  TimePoints 
Assessing the patient reported outcomes from user,collection of feedback from user and investigator  7days 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Post Marketing Surveillance 
Date of First Enrollment (India)   24/04/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Skanrays Anesthetic Workstations are continous use anesthetic workstations which are used to deliver anesthesia and provide mechanically or spontaneously induced ventilation to the adult and pediatric patients. It is capable of providing air oxygen N2O as mixture with anesthetic agents at set parameters. The purpose of this study is to confirm the clinical safety and performance of Skanrays anesthetic workstations. This study will generate the clinical evidence to support the claimed intended use.
 
Close